Phase I includes 20 to 100 healthy volunteers or individuals with the disease/condition. This study typically lasts several months and its purpose is safety and dosage. Phase II includes larger number of individual participants ranging 100-300, and phase III includes Approximately 1000-3000 participants to collect more data about the drug.[6] 70% of drugs advance to the next phase.[7]